The search for an optimal prosthetic vascular graft suitable for small vessels continues. The aim of this study was to compare a fluoropolymer passivated Dacron graft with a standard polytetrafluoroethylene graft. A sheep animal model was used. Under general anaesthesia a 5-cm length of 5-mm diameter graft was interposed into the left carotid artery. After an interval of 1, 2 or 3 months the sheep were reanaesthetized and a carotid angiogram performed before harvesting the graft. Graft patency was assessed by macroscopic inspection, angiography and histological examination. Overall, four of eight polytetrafluoroethylene grafts and three of ten fluoropolymer passivated Dacron grafts remained patent with similar patency rates at 1, 2 and 3 months. Histological examination of all available grafts showed evidence of fibrointimal hyperplasia. All but one of the occluded grafts had fibrointimal hyperplasia.
CranleyJJHafnerCD. Newer prosthetic material compared with autogenous saphenous vein for occlusive arterial disease of the lower extremity. Surgery1981; 89: 2–7.
2.
MichaelsJA. Choice of material for above-knee femoropopliteal bypass graft. Br J Surg1989; 76: 7–14.
3.
CampbellCDBrooksDHWebsterMWExpanded microporous polytetrafluoroethylene as a vascular substitute: a two year follow-up. Surgery1979; 85: 177–83.
CheshireNJWWolfeJHNNooneMAThe economics of femorocrural reconstruction for critical leg ischaemia with and without autologous vein. J Vasc Surg1992; 15: 167–75.
8.
MillerJHForemanRKFergusonLFarisI. Interposition vein cuff for anastomosis of prosthesis to small artery. Aust NZ J Surg1984; 54: 283–5.
9.
McCarthyWJPearceWHFlinnWRLong term evaluation of composite sequential bypass for limb threatening ischaemia. J Vasc Surg1992; 15: 761–70.
10.
MooreWSChvapilMSeiffertGKeownK. Development of an infection-resistant vascular prosthesis. Arch Surg1981; 116: 1403–7.
11.
PowellTWBurnhamSJJohnsonGJr. A passive system using rifampin to create an infection-resistant vascular prosthesis. Surgery1983; 94: 765–9.
ShueWBWorosiloSCDonetzAPTrooskinSZHarveyRAGrecoRS. Prevention of vascular prosthetic infection with an antibiotic-bonded Dacron graft. J Vasc Surg1988; 8: 600–5.
14.
ChervuAMooreWSChvapilMHendersonT. Efficacy and duration of antistaphylococcal activity comparing three antibiotics bonded to Dacron vascular grafts with a collagen release system. J Vasc Surg1991; 13: 897–901.
15.
HarveyRAGrecoRS. The non covalent bonding of antibiotics to a polytetrafluoroethylene-benzalkonium surface. Ann Surg1981; 194: 642–7.
16.
GrecoRSTrooskinSZDonetzAPHarveyRA. The application of antibiotic bonding to the treatment of established vascular prosthetic infection. Arch Surg1985; 120: 71–5.
17.
ModakSMSampathCFoxCLJrA new method for the direct incorporation of antibiotic in prosthetic vascular graft. Surg Gynecol Obstet1987; 164: 143–7.
18.
ShahPMModakSFoxCLPTFE graft treated with silver Norfloxacin (AgNF): Drug retention and resistance to bacterial challenge. J Surg Res1987; 42: 298–303.
19.
ShenkJSNeyALTsukayamaDTOlsonMEBubrickMP. Tobramycin-adhesive in preventing and treating PTFE vascular graft infection. J Surg Res1989; 47: 487–92.
20.
NeyALKellyPHTsukayamoDTBulbrickMP. Fibrin glue antibiotic suspension in the prevention of prosthetic graft infection. Trauma1990; 30: 1000–6.
21.
NielsenOMNoerHHJorgensenLGLorentzenJE. Gentamycin beads in the treatment of localised vascular graft infection: long term results in 17 cases. Eur J Vasc Surg1991; 5: 283–5.
22.
AvramovicJRFletcherJP. Rifampicin impregnation of a protein-sealed Dacron graft - an infection resistant prosthetic vascular graft. Aust NZ J Surg1991; 61: 436–40.
23.
StrachanCJLNewsomSWBAshtonTR. The clinical use of an antibiotic-bonded graft. Eur J Vasc Surg1991; 5: 627–32.
24.
Goeau-BrissonniereOLeportCBacourtFLebraultCComteRPechereJC. Prevention of vascular graft infection by rifampicin bonding to a gelatin sealed Dacron graft. Ann Vasc Surg1991; 5: 408–12.
25.
AvramovicJFletcherJP. Prevention of prosthetic vascular graft infection by Rifampicin impregnation of a protein-sealed Dacron graft in combination with parenteral cephalosporin. J Cardiovasc Surg (Torino)1992; 33: 70–4.
26.
FletcherJPAvramovicJKennyJSardelicF. Increased resistance to Staphylococcal graft infection by rifampicin impregnation of gelatin sealed Dacron. In: ChangJ, ed. Modern Vascular Surgery, Vol 6, (in press).
27.
CallowAD. Current status of vascular grafts. Surg Clin North Am1982; 62: 501–13.
28.
PevecWCDarlingCL'ItalienGJAbbottWM. Femoropopliteal reconstruction with knitted nonvelour Dacron versus expanded polytetrafluoroethylene. J Vasc Surg1992; 16: 60–5.
29.
ImparatoAMBraccoAKimGEZeffR. Intimal and neointimal fibrous proliferation causing failure of arterial reconstructions. Surgery1972; 72: 1007–17.
30.
EchaveVKoornickARHaimovMJacobsonJH. Intimal hyperplasia as a complication of the use of the polytetrafluoroethylene graft for femoro-popliteal bypass. Surgery1979; 86: 791–8.
31.
VeithFJGuptaSDalyV. Management of early and late thrombosis of expanded polytetrafluoroethylene (PTFE) femoropopliteal bypass graft. Favourable prognosis with appropriate reoperation. Surgery1980; 87: 581–7.
32.
HealyDAZierlerRFNichollsSLLong term follow-up and clinical outcome of carotid restenosis. J Vasc Surg1989; 10: 662–9.
33.
JohnstonKWRaeMHagg-JohnstonFive year results of a prospective study of percutaneous transluminal angioplasty. Ann Surg1987; 206: 403–13.
34.
ImparatoAMBaumanFGPearsonJElectron microscopic studies of experimentally produced fibromuscular arterial lesion. Surg Gynecol Obstet1974; 139: 497–504.
35.
ClowesAWKarnovskyMJ. Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature1977; 263: 625–6.
36.
MurdayAJGershlickAHSyndercombe-CourtYDIntimal hyperplasia in autogenous vein grafts in rabbits - a new animal model. Cardiovasc Res1983; 17: 446–51.
37.
McCannRLLarsonRMMitchenerJSIIIIntimal thickening and hyperlipidemia in experimental primate vascular autografts. Ann Surg1977; 189: 62–7.
38.
ClowesAWGownAMHansonSRReidyMA. Mechanisms of arterial graft failure. 1. Role of cellular proliferation in early healing of PTFE prostheses. Am J Pathol1985; 118: 43–54.
39.
HakeUGabbertHIversonSEvaluation of the healing of precoated vascular Dacron prosthesis. Langenbecks Arch Chir1991; 376: 323–9.
40.
KonradPDouganPBergquistD. Acute thrombogenicity of collagen coating of Dacron graft; an experimental study in sheep. Eur J Vasc Surg1992; 6: 67–72.
41.
FletcherJPDrydenMMunroRA sheep model of vascular graft infection. Aust NZ J Surg1990; 60: 801–3.
